Conception is a biotechnology startup dedicated to advancing human reproductive therapies through the creation of viable human eggs from induced pluripotent stem cells (iPSCs). By focusing on translating successful mouse research into human applications, Conception aims to eliminate age-related barriers to motherhood, facilitate genetic screening of eggs, and provide reproductive options for same-sex couples. The company's innovative approach involves deriving both germ and ovarian somatic cells from iPSCs and creating ovarian organoids to support the development of functional eggs. Committed to scientific excellence and collaboration, Conception seeks individuals with diverse backgrounds and expertise who are passionate about contributing to meaningful advancements in reproductive health.